Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 P&L / Income Statement

Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 P&L / Income Statement

Income statement for 2026-05-01 through 2026-07-31. Consolidated revenue, costs and expenses.

Revenue

30,971,000 US dollars

Cost of revenue

13,473,000 US dollars

Gross profit

17,498,000 US dollars

Total operating expenses

55,155,000 US dollars

Loss from operations

negative 37,657,000 US dollars

Other income (expense), net (calculated)

negative 6,380,000 US dollars

Net loss before provision for income taxes

negative 44,037,000 US dollars

Provision for income taxes

50,000 US dollars

Net loss

negative 44,087,000 US dollars

Undisclosed sources

30,971,000 US dollars. The filing reports revenue as one line and discloses no sources of it.

Research and development

6,796,000 US dollars

Selling, general and administrative

48,359,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.